Frances Eun-Hyung Lee

Frances Eun-Hyung Lee

Auto-generated profile, based on publicly available information

Frances Eun-Hyung Lee

Emory University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MWMatthew C. Woodruff
Matthew C. Woodruff
RRRichard P. Ramonell
Richard P. Ramonell
DNDoan C. Nguyen
Doan C. Nguyen
KCKevin S. Cashman
Kevin S. Cashman
ASAnkur Singh Saini
Ankur Singh Saini
ISIgnacio Sanz
Ignacio Sanz

1 July 2015 in Immunity
Verified
Journal Article
Closed access
JHJessica L. Halliley
Jessica L. Halliley
CTChristopher M. Tipton
Christopher M. Tipton
JLJane Liesveld
Jane Liesveld
ARAlexander F. Rosenberg
Alexander F. Rosenberg
JDJaime Darce
Jaime Darce
FLF. Eun-Hyung Lee
F. Eun-Hyung Lee

10 July 2020 in Nature Medicine
Verified
Journal Article
Closed access
SZSeth J. Zost
Seth J. Zost
PGPavlo Gilchuk
Pavlo Gilchuk
RCRita E. Chen
Rita E. Chen
JCJames Brett Case
James Brett Case
JRJoseph X. Reidy
Joseph X. Reidy
JCJames E. Crowe
James E. Crowe

31 August 2022 in Nature
Verified
Journal Article
Open access
PDF file
MWMatthew C. Woodruff
Matthew C. Woodruff
RRRichard P. Ramonell
Richard P. Ramonell
NHNatalie S. Haddad
Natalie S. Haddad
FAFabliha A. Anam
Fabliha A. Anam
MRMark E. Rudolph
Mark E. Rudolph
ISIgnacio Sanz
Ignacio Sanz
Severe SARS-CoV-2 infection1 has been associated with highly inflammatory immune activation since the earliest days of the COVID-19 pandemic2–5. More recently, these responses have been associated with the emergence of self-reactive antibodies with pathologic potential6–10, although their origins and resolution have remained unclear11. Previously, we and others have identified extrafollicular B cell activation, a pathway associated with the formation of new autoreactive antibodies in chronic autoimmunity12,13, as a dominant feature of severe and critical COVID-19 (refs. 14–18). Here, using single-cell B cell repertoire analysis of patients with mild and severe disease, we identify the expansion of a naive-derived, low-mutation IgG1 population of antibody-secreting cells (ASCs) reflecting features of low selective pressure. These features correlate with progressive, broad, clinically relevant autoreactivity, particularly directed against nuclear antigens and carbamylated proteins, emerging 10–15 days after the onset of symptoms. Detailed analysis of the low-selection compartment shows a high frequency of clonotypes specific for both SARS-CoV-2 and autoantigens, including pathogenic autoantibodies against the glomerular basement membrane. We further identify the contraction of this pathway on recovery, re-establishment of tolerance standards and concomitant loss of acute-derived ASCs irrespective of antigen specificity. However, serological autoreactivity persists in a subset of patients with postacute sequelae, raising important questions as to the contribution of emerging autoreactivity to continuing symptomology on recovery. In summary, this study demonstrates the origins, breadth and resolution of autoreactivity in severe COVID-19, with implications for early intervention and the treatment of patients with post-COVID sequelae.

14 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMatthew C. Woodruff
Matthew C. Woodruff
KBKevin S. Bonham
Kevin S. Bonham
FAFabliha A. Anam
Fabliha A. Anam
TWTiffany A. Walker
Tiffany A. Walker
CFCaterina E. Faliti
Caterina E. Faliti
ISIgnacio Sanz
Ignacio Sanz
While immunologic correlates of COVID-19 have been widely reported, their associations with post-acute sequelae of COVID-19 (PASC) remain less clear. Due to the wide array of PASC presentations, understanding if specific disease features associate with discrete immune processes and therapeutic opportunities is important. Here we profile patients in the recovery phase of COVID-19 via proteomics screening and machine learning to find signatures of ongoing antiviral B cell development, immune-mediated fibrosis, and markers of cell death in PASC patients but not in controls with uncomplicated recovery. Plasma and immune cell profiling further allow the stratification of PASC into inflammatory and non-inflammatory types. Inflammatory PASC, identifiable through a refined set of 12 blood markers, displays evidence of ongoing neutrophil activity, B cell memory alterations, and building autoreactivity more than a year post COVID-19. Our work thus helps refine PASC categorization to aid in both therapeutic targeting and epidemiological investigation of PASC.

12 September 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
DNDoan C. Nguyen
Doan C. Nguyen
SGSwetha Garimalla
Swetha Garimalla
HXHaopeng Xiao
Haopeng Xiao
SKShuya Kyu
Shuya Kyu
IAIgor Albizua
Igor Albizua
FLF. Eun-Hyung Lee
F. Eun-Hyung Lee
Human antibody-secreting cells (ASC) in peripheral blood are found after vaccination or infection but rapidly apoptose unless they migrate to the bone marrow (BM). Yet, elements of the BM microenvironment required to sustain long-lived plasma cells (LLPC) remain elusive. Here, we identify BM factors that maintain human ASC > 50 days in vitro. The critical components of the cell-free in vitro BM mimic consist of products from primary BM mesenchymal stromal cells (MSC), a proliferation-inducing ligand (APRIL), and hypoxic conditions. Comparative analysis of protein–protein interactions between BM-MSC proteomics with differential RNA transcriptomics of blood ASC and BM LLPC identify two major survival factors, fibronectin and YWHAZ. The MSC secretome proteins and hypoxic conditions play a role in LLPC survival utilizing mechanisms that downregulate mTORC1 signaling and upregulate hypoxia signatures. In summary, we identify elements of the BM survival niche critical for maturation of blood ASC to BM LLPC.